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Abstract
Irgm1 (LRG-47) is an interferon-inducible Golgi membrane associated GTPase of the mouse whose disruption causes
susceptibility to many different intracellular pathogens. Irgm1 has been variously interpreted as a regulator of homologous
effector GTPases of the IRG family, a regulator of phagosome maturation and as an initiator of autophagy in interferon-
induced cells. We find that endogenous Irgm1 localises to late endosomal and lysosomal compartments in addition to the
Golgi membranes. The targeting motif known to be required for Golgi localisation is surprisingly also required for
endolysosomal localisation. However, unlike Golgi localisation, localisation to the endolysosomal system also requires the
functional integrity of the nucleotide binding site, and thus probably reflects transient activation. Golgi localisation is lost
when Irgm1 is tagged at either N- or C-termini with EGFP, while localisation to the endolysosomal system is relatively
favoured. N-terminally tagged Irgm1 localises predominantly to early endosomes, while C-terminally tagged Irgm1 localises
to late endosomes and lysosomes. Both these anomalous distributions are reversed by inactivation of the nucleotide
binding site, and the tagged proteins both revert to Golgi membrane localisation. Irgm1 is the first IRG protein to be found
associated with the endolysosomal membrane system in addition to either Golgi (Irgm1 and Irgm2) or ER (Irgm3)
membranes, and we interpret the result to be in favour of a regulatory function of IRGM proteins at cellular membrane
systems. In future analyses it should be borne in mind that tagging of Irgm1 leads to loss of Golgi localisation and enhanced
localisation on endolysosomal membranes, probably as a result of constitutive activation.
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Introduction
The interferon-inducible immunity-related GTPases (IRG
proteins, previously named p47 GTPases) are resistance factors
against intracellular pathogens in mice. Irgm1 has been reported
to be a uniquely powerful member of the IRG family, because
mice deficient in this gene showed complete loss of resistance to all
bacterial and protozoal pathogens tested so far (reviewed in [1,2]).
Several other IRG proteins have also been shown to be required
for complete resistance to Toxoplasma gondii (Irgm3, Irgd, Irgb6)
(reviewed in [3]) or Chlamydia trachomatis (Irgm3 and Irgb10) [4,5],
but resistance functions against other pathogens have not been
documented for these proteins. The resistance mechanisms of IRG
proteins are still unclear. In the case of resistance to T. gondii,
which has been most comprehensively documented, interest is
focused on the unexplained ability of IRG proteins to cause
disruption of the parasitophorous vacuole, resulting in the death of
the parasite in the cytosol [6,7]. Since, alone of the IRG proteins
assayed, Irgm1 has never been found at the parasitophorous
vacuole, it is clear that this IRG protein is not directly involved in
the observed vesiculation and disruption of the parasitophorous
vacuole membrane. It has, however, been shown that Irgm1, with
its closest homologues Irgm2 and Irgm3, is required for regulating
the GTPase cycle of the other IRG proteins in the cytoplasm [8].
It follows that the general susceptibility of Irgm1-deficient mice to
protozoal infection may be accounted for as a regulatory failure
that disables the IRG-dependent resistance mechanism. It is also
possible that dysregulation of the IRG system in absence of Irgm1
may lead to cytopathic consequences that are manifested as defects
in hematopoiesis [9], lymphocyte development and/or homeosta-
sis [10],and macrophage functioning [11]. Other mechanisms
have, however, been proposed for the role of Irgm1 in these and
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Mycobacteria, which is lost in Irgm1 deficiency: these include
accelerated lysosome fusion and/or acidification of phagosomes
[12,13], and induction of autophagy [14,15].
There are about 18 genes encoding interferon-inducible IRG
proteins in the C57BL/6 genome. The proteins have been divided
into two major sequence subfamilies, informally designated GKS
and GMS [16]. GMS subfamily members Irgm1, Irgm2 and
Irgm3 have a most unusual methionine (GX4GMS) in the position
of an otherwise universally conserved lysine (GX4GKS) in the P-
loop of the G1 motif of the nucleotide-binding site. Unlike the
GKS protein, Irga6, for which a crystal structure is available [17],
the GMS subfamily proteins have proved difficult to purify
without tags and little is known of their structural or biochemical
properties. Nevertheless there is suggestive evidence from
immunoprecipitated material and from fusion proteins that,
despite the remarkable modification in the G1 motif, the GMS
subfamily proteins are able to bind and hydrolyse GTP [18,19].
The expression of Irgm1, together with other IRG proteins
(except Irgc), is strongly induced by interferons [16]. In IFNc-
induced cells, the IRG proteins associate with cellular membranes
to different extents. Irgm1 is exceptional among IRG proteins
assayed in that it is exclusively membrane-associated, with no
detectable cytosolic pool [20]. Although no transmembrane
domain has been identified within the Irgm1 sequence, the
protein behaves like an integral membrane protein in resistance to
extraction with high salt, sodium carbonate or urea [20]. By
immunofluorescence, native, IFNc-induced Irgm1 localises strong-
ly to Golgi membranes and to a lesser extent to unidentified
cytoplasmic membrane systems [19,20]. The Golgi localisation
depends on a predicted amphipathic helix in the C-terminal
domain of the protein, the aK-helix [20], but the basis for
localisation to other cytoplasmic membrane systems has not been
studied. Upon latex-bead phagocytosis, native Irgm1 rapidly re-
localises in IFNc-induced fibroblasts and macrophages to F-actin-
rich plasma membrane ruffles associated with phagocytic cups,
and remains associated with the phagosomes as they mature into
phagolysosomes and become LAMP1 positive [20]. Uptake of M.
bovis BCG by macrophages stimulates similar relocation of Irgm1
to the bacterial phagosome and phagolysosome [19].
In this study we examine in detail several aspects of the
localisation of Irgm1 to cytoplasmic compartments. Building on
the earlier observation [20] that the 20-residue amphipathic aK
helix of Irgm1 is sufficient to target EGFP to the Golgi apparatus,
we show that this sequence can also target EGFP to a cytoplasmic
membrane system identified as lysosomes and late endosomes, but
not to latex-bead phagosomes. We show that the aK helix could
be also used in the form of a synthetic biotinylated peptide to
target a labelled streptavidin complex to Golgi membranes in
fixed, permeabilized cells. This biotin-peptide probe also stained
cytoplasmic organelles outside the Golgi that we were able to show
corresponded to late endosomes and lysosomes. This novel
association proved to reflect the previously documented non-
Golgi cytoplasmic localisation of native, IFNc-induced Irgm1,
which had not been located to a specific compartment [20]. Irgm1
has thus a constitutive association with the endolysosomal
membrane system in addition to the Golgi apparatus, a unique
property among IRG proteins tested so far. The lysosomal
localisation of Irgm1 is mediated by the same amphipathic helix
that mediates Golgi targeting.
We observed earlier that N-terminally EGFP-tagged, and C-
terminally FLAG-tagged Irgm1 both mis-localise in cells, but the
observations were not followed up and the compartments involved
were not identified [20]. We now show that N and C terminal
EGFP tags on Irgm1 both lead to loss of Golgi localisation and
localisation to other membrane compartments. The mis-localisa-
tion of tagged Irgm1 is dependent on nucleotide binding, and we
suggest that Golgi localisation is a default state probably associated
with an inactive GDP-bound state of the protein. The mis-
localisation of Irgm1 N- or C-terminally tagged with EGFP
suggests that functional experiments employing such constructs
[13–15,19] may need to be interpreted cautiously.
Results
IFNc-Induced Irgm1 Localises to Golgi Apparatus and
Late Endocytic/Lysosomal Compartments
We previously reported that IFNc-induced Irgm1 (LRG-47) is
exclusively membrane-bound and localises in large part to the
Golgi apparatus in L929 fibroblasts, TIB-75 hepatocytes and Raw
264.7 macrophages. This localisation is mediated by an amphi-
pathic helix near the C-terminus [20] We noted that IFNc-
induced Irgm1 has a further cytoplasmic signal throughout the cell
periphery of which the subcellular localisation remained to be
identified. In the present study, we employed the microscopically
favorable murine embryonic fibroblasts (MEFs) to characterise the
intracellular localisation of Irgm1 in more detail.
In IFNc treated MEFs, both goat polyclonal anti-Irgm1
antiserum P20 and the mouse monoclonal anti-Irgm1 antibody
1B2 gave a focused adnuclear signal in all cells, though of variable
intensity, and additional distributed granular signals, more or less
conspicuous in different cells (Figure 1). High and low Irgm1
staining intensity for the two compartments were uncorrelated
(Supplementary Table S1). As previously reported [20], the
adnuclear signal accurately overlapped with both cis-Golgi matrix
protein GM130 (Figure 1A panels a–c) and trans-Golgi/trans-Golgi
network protein TGN38 (Figure 1A panels d–f). Less accurate co-
localisation was observed with cation-independent mannose 6
phosphate receptor (CI-M6PR), which is predominantly localised
in late endosomes (Figure 1A panels g–i); Irgm1 localises rather to
places adjacent to or partially overlapping with CI-M6PR positive
compartments. Furthermore, the more widely distributed punctate
signal of Irgm1 accurately co-localised with the late endosome/
lysosome marker LAMP1 (Figure 1B panels a–d)). By comparison,
Irgm2 localised exclusively to Golgi apparatus, as reported earlier
[1] with no extra signal overlapping with LAMP1 (Figure 1B panel
c). To confirm the apparent lysosomal localisation of Irgm1, the
acidotropic dye LysoTracker was loaded and cells were co-stained
with anti-Irgm1 antibody 1B2. Irgm1 was found to accumulate
around the LysoTracker enriched compartments (Figure 1B panel
e–g). By comparison, endogenous Irgm1 rarely co-localised with
transferrin-labelled early and recycling endocytic compartments
(Figure 1C). Taken together, we conclude that native, IFNc-
induced Irgm1 is variably associated with acidified late endocytic/
lysosomal compartments in addition to Golgi apparatus.
We previously reported that a predicted amphipathic helix near
the C terminus of Irgm1 (named aK helix after the equivalent
element in the known Irga6 structure) is responsible for the
localisation of the protein to Golgi membranes [20]. The aK helix
is a true targeting motif since, as a C-terminal tag, it was sufficient
to target EGFP accurately to the Golgi apparatus as defined by
GM130 staining [20]. Disruption of amphipathicity by glutamate
insertion into the helical region abolished the Golgi localisation in
both EGFP-Irgm1 aK construct and Irgm1 full-length protein.
Since we now show that IFNc-induced Irgm1 also localises to
lysosomes, we ask whether the native aK helix of full-length Irgm1
is also necessary for lysosomal localisation. Full length Irgm1 and
the ins 362,367E Irgm1 mutant, in which the amphipathicity of
Localisation of Irgm1 (LRG-47)
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[20], were transiently expressed in un-induced MEFs (Figure 2).
Wild type Irgm1 showed both Golgi and lysosomal association like
the endogenous IFNc-induced protein (Figure 2 panels a–c). In
these cells the co-localisation with LAMP1 was even more striking
than in IFNc-induced cells. Irgm1 ins 362, 367E mutant was
distributed as dotty structures throughout the cytoplasm that
showed neither Golgi nor lysosomal localisation (Figure 2 panels
d–f and [20]). This new localization, which was not identified, may
indicate the present of another membrane-targeting motif in
Irgm1 and deserves further analysis. Thus the native amphipathic
aK helix is required for both Golgi and lysosomal targeting of full
length Irgm1 protein.
The Amphipathic aK Helix Near the C-Terminus of Irgm1
Shows Golgi and Lysosomal Targeting Property
We previously observed that the EGFP-Irgm1 aK construct was
often associated with a cytoplasmic compartment in addition to
Golgi-marker-positive compartments in some transfected cells [20].
We therefore now analysed the intracellular localisation of the
Figure 1. Localisation of IFNc-induced endogenous Irgm1. (A) MEFs were treated with 200 U/ml IFNc for 24 hours, fixed and stained for Irgm1
with goat antiserum P20 (a–c, g–l) or mouse monoclonal antibody 1B2 (d–f) (both directed against Irgm1) and the indicated marker proteins. Irgm1
accurately co-localised with GM130 (a–c) and TGN38 (d–e), and localised adjacent to, or partially co-localised with, the CI-M6PR positive
compartments (g–i). (B) MEFs were treated with 200 U/ml IFNc for 24 hours. Cells were either fixed and stained for Irgm1, LAMP1 and Irgm2 using
1B2, 1D4B, and H53 immunoreagents, respectively (a–d), or further incubated with 50 nM LysoTracker Red DND-99 for 30 minutes in complete
medium, and stained for Irgm1 with 1B2 antibody (e–g). Irgm1 was found to associate with LAMP1 positive compartments (a–d) and accumulate
around the LysoTracker enriched compartments (e–g) in addition to Golgi localisation. Irgm2 (c) localises exclusively to the Golgi apparatus. (C) After
treatment with 200 U/ml IFNc for 24 hours, MEFs were incubated with Alexa-Fluor-546-labelled transferrin for 5 minutes (a–c) or pulsed with labelled
transferrin for 10 minutes, then chased for 30 minutes (d–f). Cells were then fixed and stained for Irgm1 with P20 goat antiserum. The granular signals
from Irgm1 were not found convincingly associated with transferrin-positive compartments.
doi:10.1371/journal.pone.0008648.g001
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observed that when this construct was highly expressed in cells the
construct accumulated in aggregates in the cytoplasm, sometimes
associated with obviously cytopathic changes such as cell shrinkage
and rounding up (not shown). The following observations therefore
apply only to cells showing relatively low expression levels of the
construct and no evident cytopathic changes. In such cells there was
considerable heterogeneity in the expression pattern of the EGFP-
Irgm1 aK construct. Figure 3 shows the differential localization of
the EGFP-Irgm1 aK construct in individual cells from a single
transfected population. When co-stained for GM130 as a Golgi
marker, in some transfected cells the EGFP-Irgm1 aK construct
localisedlargelytotheGolgiapparatuswithonlyaweak,distributed,
diffuse background over the rest ofthe cytoplasm (Figure 3 panelsa–
c). In other cells EGFP-Irgm1 aK localised to the Golgi apparatus as
defined by GM130 co-localisation but additionally showed a more
orlesspunctatedistributioninthecytoplasm(Figure3panelsd–f).In
further transfected cells there was no co-localisation of transfected
EGFP-Irgm1aKwithGM130atallandallthetransfectedconstruct
was present in cytoplasmic punctae (Figure 3 panels g–i). Some but
not all of the cytoplasmic punctae co-localised with the lysosomal
protein LAMP1 (Figure 3 panels j–o). Thus the aK amphipathic
helix can target EGFP in vivo to both Golgi and lysosomal
compartments. Additional cytoplasmic accumulations of EGFP-
Irgm1 aK remain unidentified. The phenotypic diversity between
cells is unexplained, but seems also to reflect in part the behaviour of
native induced Irgm1 shown in Figure 1.
Since native Irgm1 is rapidly recruited to latex-bead phago-
somes ([20] and see below), we next asked whether the aK helix
also showed phagosomal accumulation. EGFP-Irgm1 aK was
expressed by transfection in MEFs and cells were incubated with
2-mm latex beads to induce phagocytosis. Even though co-
localisation was seen between EGFP-Irgm1 aK and LAMP1 in
cells taking up beads (Figure 4 panels e, f, g arrows), latex bead
phagosomes remained negative or very weakly stained for EGFP-
Irgm1 aK (Figure 4 panels a, e, i). Thus the Irgm1 aK helix alone
is not sufficient for the active accumulation of full-length Irgm1 on
the phagosome.
The Overall Amphipathicity of the aK Helix and the
Identity of the Non-Hydrophobic Residues Both
Contribute to the Golgi and Lysosome Localisation of the
aK Helix
To investigate the possible mechanisms of subcellular localisa-
tion of Irgm1, an alanine mutagenesis scan was performed based
on the targeting construct EGFP-Irgm1 aK. Single mutations of
hydrophobic residues (C356A; I358A; V359A; F362A; F363A;
L365A; L366A not shown) double mutations (F362A F363A and
L365A L366A not shown) and even the quadruple mutant (F362A
F363A L365A L366A, Figure 5A) had no marked influence on
EGFP-Irgm1 aK localisation. Cells with predominantly Golgi-
localised (not shown) mixed Golgi and LAMP1 (Figure 5A panel
a–c) or predominantly LAMP1-associated (Figure 5A panels d–f)
EGFP-aK mutant signals, were seen, as with the wild-type aK
(Figure 4). Single mutations of the hydrophilic residues also had no
effect on localisation. Again, cells with predominantly Golgi or
predominantly LAMP1 localisation were seen (N360A Figure 5B,
panels a–c, d–f;R364A Figure 5B, panels g–i, j–l);R367A
Figure 5B, panels m–o, p–r). However, if more than one charged
or polar residue was mutated to alanine both Golgi and lysosomal
localisation were completely abolished (N360A, R364A; R364A,
R367A; N360A, R364A, R367A; Figure 5C). These latter mutants
were distributed in an unspecific manner throughout the
cytoplasm and were possibly largely cytosolic. The increasing
intensity generally around the Golgi area, though not concentrated
on Golgi membranes, probably simply reflects the extra thickness
of the cytoplasm at this site. These results suggest that both the
overall amphipathicity of the aK helix and the identity of the non-
hydrophobic residues contribute together to the membrane and
Golgi/lysosome localisation of the aK helix, and it is possible that
the specificity for Golgi and lysosomal membranes is determined
by the identity of the polar residues.
Synthetic aK Amphipathic Peptide Mimics the
Localisation of Endogenous Irgm1
Biochemical studies showed that Irgm1 behaves like an integral
membrane protein, even though no transmembrane domain has
Figure 2. Amphipathic aK helix is responsible for lysosomal targeting of full length Irgm1 protein. MEFs were transfected with plasmids
encoding either Irgm1 wild type (a–c) or the ins 362, 367E mutant (d–f) for 24 hours in the absence of IFNc. Cells were then fixed and stained for
Irgm1 and LAMP1. Wild type Irgm1 is strongly associated with the LAMP1 positive compartment, while Irgm1 ins 362, 367E mutant showed granular
signals throughout cytoplasm which do not overlap with LAMP1 signals. Nuclei were labelled with DAPI.
doi:10.1371/journal.pone.0008648.g002
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study, it was also demonstrated that Irgm1 exclusively associates
with the membrane fraction of the cell [20]. Attempts to purify
untagged recombinant Irgm1 protein failed due to insolubility
(not shown). To investigate the possible mechanisms of Irgm1
localisation, a peptide corresponding to the targeting amphipath-
ic sequences (SK*LRLMTCAIVNAFFRLLRFLPCVCC) of
Irgm1 was synthesized. The lysine in position 2 (K*) was
covalently conjugated with biotin. Thus the peptide could be
loaded onto fluorochrome-conjugated streptavidin protein, which
has four biotin binding sites, to form a tetrameric, fluorescent
peptide-streptavidin complex. The localisation of this complex
was then examined directly on fixed, permeabilized cells. The
procedures for making and using this tetramer system are
described in Materials and Methods. Figure 6 shows the staining
pattern of Cy3 labelled streptavidin-Irgm1 aK tetrameric
complexes in MEFs. Cy3-labeled streptavidin alone was used as
control and pictures were taken with the same exposure time
(Figure 6 panels a, b). The streptavidin-Irgm1 aK complex
staining shows both perinuclear and vesicular structures corre-
sponding to the localisation of endogenous Irgm1 protein
(Figure 6 panels c, d, g, h). GM130 (Figure 6 panel e) and
LAMP1 (Figure 6 panel i) were additionally used to identify the
Golgi apparatus and lysosomes. Streptavidin-Irgm1 aK com-
Figure 3. EGFP-Irgm1 aK localises to both Golgi and lysosomes. MEFs were transfected with an expression plasmid encoding EGFP-Irgm1 aK
in the absence of IFNc (20). 24 hours later cells were fixed and stained for either GM130 (a–i) or LAMP1 (j–o). Transfected cells stained with GM130
showed 3 rather different staining patterns for EGFP-Irgm1 aK: clear Golgi staining with only diffuse staining elsewhere (a–c), clear Golgi staining and
punctate staining elsewhere (d–f), and only punctate staining without significant Golgi staining (g–i). When stained for LAMP1, cytoplasmic dots of
EGFP-Irgm1 aK, without (j–l) or with (m–o) Golgi localisation were more or less strongly associated with LAMP1-positive vesicles. Nuclei were labelled
with DAPI.
doi:10.1371/journal.pone.0008648.g003
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both Golgi apparatus and lysosomes. Co-localisation with
GM130 was seen also in cells not induced with IFNc (data not
shown), suggesting that the targeting of the complex was due to a
component unresponsive to IFNc and not due to direct
association with endogenous Irgm1. There was, however, more
diffused staining with the synthetic complexes, perhaps due to the
intrinsic hydrophobic character of the peptide. These results
demonstrate that the streptavidin-aK peptide complex closely
resemble the localisation of endogenous Irgm1 and provides a
valuable novel method to investigate the function of targeting
motifs of proteins.
Both N and C Terminal EGFP-Tags Cause Mislocalisation
of Irgm1
The proposed autophagy-induction function of Irgm1 is
largely based on over-expression experiments using C-terminally
EGFP-tagged Irgm1 [14,15]. However, we observed earlier that
both N and C terminally tagged Irgm1 misbehave in cells [20].
To investigate to which compartments tagged Irgm1 localises in
cells, both N and C terminally EGFP-tagged Irgm1 were
expressed in MEFs and co-stained with Golgi markers,
endocytosed transferrin and LAMP1 (Figure 7). EGFP-Irgm1
and Irgm1-EGFP (pF25, [13–15]) both showed diffuse vesicular
and dotty expression patterns throughout the cytoplasm. Co-
localisation with the Golgi protein GM130 and TGN38 was
abolished in all cells (Figure 7A and B). Many of these vesicular
and dotty signals strongly co localised with transferrin-labelled
early endosomes and recycling endosomes (Figure 7C). As
described earlier, no co-localisation was found between native
IFNc-induced Irgm1 and early and recycling endosomes
(Figure 1C). The Irgm1-EGFP construct showed strong co-
localisation with LAMP1 while for EGFP-Irgm1 the lysosomal
association was generally reduced (Figure 7D). Since Irgm1
associates with membranes independently of IFNc-induced
factors [20], we asked whether IFNc could influence the
mislocalisation of EGFP-Irgm1 and Irgm1-EGFP. The two
constructs were transfected into MEFs simultaneously induced
with IFNc. Both EGFP-Irgm1 and Irgm1-EGFP mislocalised
also in IFNc-induced cells (data not shown). In conclusion,
neither N nor C terminally EGFP-tagged Irgm1 localises to Golgi
membranes, while both continue to localise to LAMP1 positive
compartments and mislocalise to differing extents to early and
recycling endocytic compartments.
C-terminally Irgm1-EGFP-tagged constructs have been used
elsewhere both for studies of autophagy [14,15] and mycobacterial
resistance [12,19] in IFNc-induced RAW264.7 macrophages.
These cells are not ideal for immunofluorescence localization
because of their complex 3-dimensional morphology. Nevertheless
we have been unable to confirm the claimed Golgi localization of
C-terminally EGFP-tagged Irgm1 in these cells (Supplementary
Figure S1 panels a–l). The construct is localized throughout the
cytoplasm and is hard to resolve away from the Golgi. However
the Golgi itself is very well defined by GM130 and there is no
tendency towards concentration or enrichment of the Irgm1-
EGFP corresponding to the Golgi, either in resting or IFNc-
induced RAW264.7 cells. In contrast, the localization of native,
IFNc-induced Irgm1 in RAW cells, is closely associated with Golgi
membranes, as it is in MEFs (Figure S1, panels m–p). Thus the
mislocalisation of N-terminally EGFP-tagged Irgm1 is not a cell-
type-specific characteristic of MEFs, but a fixed characteristic of
the construct.
Figure 4. EGFP-Irgm1 aK is not recruited to phagosomes. EGFP-Irgm1 aK was transiently transfected into MEFs for 24 hours in the absence of
IFNc. During transfection, cells were incubated with 2-mm latex beads overnight. Cells were then fixed and stained for LAMP1. EGFP-Irgm1 aK was not
associated with latex bead phagosomes (arrowheads), whether the association with other cellular compartments was Golgi only (a–d), lysosomal only
(e–h) or both Golgi and lysosomal (i–l). Despite not associating with latex bead phagosomes, EGFP-Irgm1 aK associated normally with the LAMP1
compartment elsewhere (arrows). Nuclei were labelled with DAPI.
doi:10.1371/journal.pone.0008648.g004
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mutants of the hydrophilic residues (N360A;R364A;R367A; Figure 6B including enlargements (for d, e, f)), or combined mutants of more than one
hydrophilic residues (N360A, R364A; R364A, R367A; N360A, R364A, R367A; Figure 6C) were transfected into MEFs for 24 hours. Cells were then fixed
and staining for GM130 or LAMP1. Only when more than one hydrophilic residue was mutated to alanine, the EGFP-Irgm1 aK no longer localised to
Golgi or lysosomes. These mutants localised to unidentified endomembrane-like structures or are delocalized and possibly cytosolic. Nuclei were
labelled with DAPI.
doi:10.1371/journal.pone.0008648.g005
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Dependent
Irgm1 is associated with Golgi membranes independently of
nucleotide binding [20]. To test whether nucleotide binding
influences the mislocalisation of Irgm1 caused by EGFP tagging,
the Irgm1 nucleotide binding deficient mutant (S90N) was tagged
with EGFP at N or C terminus and expressed in MEFs. Both
fusion proteins accurately co-localised with Golgi protein TGN38
and GM130 (Figure 8 and not shown) but more cytoplasmic
reticular and vesicular signals were also seen. The expression
Figure 6. Synthetic aK amphipathic peptide mimics the localisation of endogenous Irgm1. MEFs were treated with 200 U/ml IFNc for
24 hours and then fixed with 3% PFA in PBS. Cy3-streptavidin-peptide solutions (0.33 mM streptavidin) were prepared as described in Materials and
Methods. Antibodies against the indicated proteins were added to the streptavidin-peptide solution and the mixtures used as primary reagents in
immunofluorescence staining. Streptavidin (0.33 mM final) alone (a) was used as control. Image (a) and (b) were taken at the same exposure time.
Colocalisation was seen between streptavidin-Irgm1 aK peptide and endogenous Irgm1 at both Golgi apparatus and lysosomes.
doi:10.1371/journal.pone.0008648.g006
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similar to the localisation of untagged nucleotide-binding deficient
Irgm1 (S90N) [20].
Phagosomal Accumulation of Irgm1 Is Nucleotide
Dependent, but IFNc Independent
In L929 fibroblasts and Raw264.7 macrophages, IFNc-induced
Irgm1 is rapidly recruited to active plasma membrane upon
phagocytosis and remains associated with phagosomes as they
mature [20]. It was also reported that Irgm1 associates with Golgi
apparatus in an IFNc and nucleotide independent manner [20].
We therefore asked whether Irgm1 can accumulate on latex bead
phagosomes independently of IFNc and if so, whether the
association with phagosomes is regulated by nucleotide binding.
Irgm1 wild type and nucleotide binding deficient mutant
Irgm1(S90N) were expressed in MEFs in the absence of IFNc,
and phagocytosis was initiated by incubating with 2-mm latex
beads overnight. Wild type Irgm1 strongly associated with latex
bead-phagosomes while accumulation of Irgm1(S90N) on the
phagosomal membrane was much reduced (Figure 9A). Trans-
fected Irgm1 also co-localised with LAMP1 positive compartments
in unstimulated cells taking up latex beads (Figure 9A arrows), as
well as in cells not involved in phagocytosis (not shown).
Irgm1(S90N) still showed Golgi localisation but lysosomal
distribution was largely abolished (Figure 9A panels e–h).
Therefore, the accumulation of Irgm1 on phagosomes is
nucleotide dependent, but IFNc independent.
As shown above, Irgm1-EGFP showed strong lysosomal
association, while EGFP-Irgm1 did not. Consistent with this
observation, Irgm1-EGFP accumulated strongly on latex bead
phagosomes whereas EGFP-Irgm1 was absent or only very weakly
present on phagosomes (Figure 9B). Like untagged Irgm1, the
Figure 7. Localisation of EGFP-tagged Irgm1. (A) N-terminally EGFP-tagged Irgm1 (EGFP-Irgm1) or (B) C-terminally EGFP-tagged Irgm1 (Irgm1-
EGFP, pF25) were transfected into MEFs. 24 hours later, cells were fixed and stained for GM130 (a–c) and TGN38 (d–f). Both constructs were absent
from the Golgi apparatus. Nuclei were labelled with DAPI. (C) EGFP-Irgm1 (a–f) or Irgm1-EGFP (pF25, g–l) were transfected into MEFs. 24 hours later
cells were incubated with Alexa-Fluor-546-labelled transferrin for 5 minutes (a–c, g–i) or pulsed with labelled transferrin for 10 minutes, then chased
for 30 minutes (d–f, j–l). Cells were then fixed in 3% PFA in PBS. The vesicular and dotty signals from EGFP-Irgm1 and Irgm1-EGFP strongly overlap
with transferrin-labelled early and recycling endosomes. (D) EGFP-Irgm1 (a–c) or Irgm1-EGFP (d–f, pF25) were transfected into MEFs. 24 hours later,
cells were fixed and stained for LAMP1. Irgm1-EGFP was strongly colocalised with LAMP1 while lysosomal association of EGFP-Irgm1 was largely but
not completely abolished. Nuclei were labelled with DAPI.
doi:10.1371/journal.pone.0008648.g007
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by nucleotide binding. Irgm1(S90N)-EGFP no longer associated
with latex bead phagosomes (Figure 9C).
Discussion
The different members of the mouse IRG resistance protein
family show different associations with cellular membranes. Unlike
all the other IRGs, which have a more or less prominent cytosolic
component, Irgm1 has been found exclusively in membrane-
bound form in cells. Although no transmembrane domain could
be identified in the sequence, Irgm1 behaves like a transmembrane
protein in biochemical assays [20]. In L929 fibroblasts, TIB-75
hepatocytes and Raw 264.7 macrophages, Irgm1 localises
conspicuously to cis- and medial-Golgi membranes with an
additional cytoplasmic signal [20]. In the present study, by using
TGN38 as a trans-Golgi and trans-Golgi network (TGN) marker,
the Golgi localisation domain of Irgm1 is extended to these
compartments (Figure 1A). We also show that the additional
cytoplasmic signals of Irgm1 overlap with those of LAMP1, which
marks late endosomes and lysosomes. This observation is
confirmed by co-localisation of Irgm1 with compartments
enriched in the acidotropic dye LysoTracker (Figure 1B). We
noted that, compared to the universal Golgi localisation of Irgm1,
the signal intensity of Irgm1 in the LAMP1-positive compartments
varied in different individual cells, from conspicuous to hardly
detectable. Since MEFs are isolated from mouse embryos and
constitute a developmentally and morphologically heterogeneous
population, the variable degrees of lysosomal association of Irgm1
could correlate with different states of individual cells, with stages
of the cell cycle or with other undefined factors. Native
endogenous Irgm1 is scarcely if at all detectable on early and
recycling endosomes defined by early and late uptake of
fluorochrome-labelled transferrin (Figure 1C). Taken together,
we show here for the first time that the IFNc-induced endogenous
Irgm1 localises to the late endocytic/lysosomal (LAMP1-positive)
compartments in addition to the Golgi apparatus in the absence of
infection. Irgm1 is the first IRG protein to be shown to localise to
the endosomal/lysosomal membrane system.
We further showed in MEFs that both N and C terminally
EGFP-tagged Irgm1 (EGFP-Irgm1 and Irgm1-EGFP, respectively)
localise differently from native Irgm1. Neither form of tagged
protein localized to the Golgi apparatus (Figure 7A and 7B). In a
further difference from the native protein, Irgm1-EGFP showed
significant association with LAMP1-positive compartments in all
transfected cells, in contrast to the variable lysosomal association of
IFNc-induced endogenous Irgm1 (Figure 7D). Unlike endogenous
Irgm1, however, Irgm1-EGFP also localized to early and recycling
endosomes defined by the uptake of transferrin (Figure 7C). N-
terminally tagged Irgm1 showed still more divergent behaviour. In
addition to failing to localise to the Golgi, EGFP-Irgm1 also
associated with LAMP1-positive compartments very weakly, if at
all. The construct was distributed mainly in early and recycling
endosomes as well as some other undefined, non-Golgi, non-
LAMP1-positive, vesicular structures (Figure 7C and 7D). The
observations on EGFP-Irgm1 have been confirmed in Raw264.7
macrophages (Supplementary Figure S1). It has been reported that
Irgm1-EGFP (pF25) co-localised with MDC and LC3 positive
compartments, suggesting that Irgm1 associates with autophago-
somes and therefore has a pro-autophagy function in macrophages
[14,15]. The present results suggest that the association of EGFP-
tagged Irgm1 with autophagosomes may result from transfer of the
protein from lysosomes or other compartments of the endocytic
system, but not from the Golgi apparatus, where the fusion protein
fails to localize. Because of the altered localization of the EGFP-
Irgm1 constructs, the association of endogenous Irgm1 with
autophagic compartments will bear careful examination.
We found that both N and C terminally EGFP-tagged
nucleotide-binding deficient Irgm1(S90N) localised to the Golgi
with little if any mislocalisation (Figure 8), indicating that the
targeting of Irgm1 to different compartments is controlled by the
nucleotide binding state of the protein. Golgi localisation
presumably reflects the inactive or GDP-bound state of the
protein since nucleotide-binding deficient Irgm1 (S90N), whether
tagged with EGFP or not, localises to Golgi. Correspondingly, the
endosomal and lysosomal localisation of EGFP-tagged Irgm1 may
reflect the activated or GTP-bound form of Irgm1, suggesting that
the tags may cause constitutive or inappropriate activation, or
inhibit nucleotide exchange. We have recently shown that another
IRG protein, Irga6, normally rests in cytoplasmic compartments
in the inactive state, but depends on continuous regulatory
interactions with Irgm1, Irgm2 and Irgm3 to inhibit spontaneous
Figure 8. Mislocalisation of EGFP-tagged Irgm1 is nucleotide-dependent. EGFP-Irgm1 S90N (a–c) and Irgm1-EGFP S90N (d–f) were
transfected into MEFs for 24 hours. Cells were then fixed and stained for TGN38. Both constructs co-localised with TGN38, although a significant
proportion of transfected proteins displayed additional cytoplasmic signals. Nuclei were labelled with DAPI.
doi:10.1371/journal.pone.0008648.g008
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PLoS ONE | www.plosone.org 10 January 2010 | Volume 5 | Issue 1 | e8648Figure 9. Phagosomal accumulation of Irgm1 is nucleotide-dependent, but IFNc-independent. (A) Irgm1 wild type (a–d) and S90N
mutant (e–h) were transfected into MEFs in the absence of IFNc for 24 hours. During transfection, cells were incubated with 2-mm latex beads
overnight. Cells were then fixed and stained for Irgm1 and LAMP1. Irgm1 accumulated around the latex beads phagosomes (seen as refringent
spheres) while the loss of the nucleotide-binding site completely abolished the phagosomal accumulation. Arrows indicate the co-localisation of
transfected wild type Irgm1 with LAMP1 positive compartments outside latex-bead phagosomes. (B) EGFP-Irgm1 or Irgm1-EGFP were transfected
into MEFs for 24 hours in the absence of IFNc. During transfection, cells were also incubated with 2-mm latex beads overnight. Cells were then fixed
and stained for LAMP1. Irgm1-EGFP accumulated around the latex bead phagosomes while EGFP-Irgm1 did not. (C) The same experiments were
performed as in (B) but using the nucleotide-binding deficient mutants (S90N) of N- and C-terminally EGFP-tagged Irgm1. Both mutants were absent
from latex bead phagosomes. Nuclei were labelled with DAPI.
doi:10.1371/journal.pone.0008648.g009
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GTPase family, members of which show common properties of
GTP-dependent oligomerisation and cooperative activity [21]. We
have shown that Irgm1 can interact with itself in a yeast 2-hybrid
system, and self-interaction is abolished by destroying the
nucleotide-binding motif (S90N) [8]. It may be that EGFP-tagged
Irgm1 proteins form dimers in cells [22] resulting in premature
activation through the enforced proximity of two G-domains.
We showed recently that Irgm1, as well as its close relatives,
Irgm2 and Irgm3, function primarily to regulate the activation of
other ‘‘effector’’ members of the IRG protein family such as Irga6,
Irgb6 and Irgd [8]. There we argued that the regulatory
interactions should occur primarily at cytoplasmic membranes
rather than free in the cytosol. An obvious problem with that
argument, however, was the apparent absence of a regulatory
IRGM protein on the endo-lysosomal system. With the data of the
present report, however, endolysosomal membranes can now
potentially be included in regulatory activity mediated by Irgm1.
Golgi localisation of Irgm1 is mediated by the predicted
amphipathic aK helix near the C-terminus, a sequence that can
also target EGFP to the Golgi [20]. We show here that the same
sequence will also target EGFP to lysosomes defined by LAMP1.
IFNc-induced endogenous Irgm1 also showed different levels of
lysosomal association, with strong lysosomal signals in some cells
and hardly detectable signals in other cells. The signal intensities in
the two compartments varied independently of each other
(Supplementary Table S1). The mechanism for this ambiguous,
possibly dynamic localisation behaviour is unclear: as noted above,
it may correlate with spontaneous activation of the GTPase cycle.
The Irgm1 aK helix was required not only for targeting EGFP
to Golgi and lysosomes, but also for the correct localisation of full-
length protein ([20] and this report). A mutant with glutamate
insertions to disrupt the amphipathicity of aK helix in full-length
Irgm1 distributed as uncharacteristic dotty structures throughout
the cytoplasm showing no overlap with GM130 or LAMP1 ([20]
and Figure 2). The implication of this observation is that Golgi and
lysosomal localisation of full-length Irgm1 depends on the
amphipathicity of the aK helix. However, although Irgm1 aK
helix is sufficient to target EGFP protein to Golgi and lysosomes, it
is not sufficient to target EGFP to the latex bead phagosomes
(Figure 4). Since accumulation of full-length Irgm1 on phagosomes
depended on the integrity of the nucleotide-binding motif, it seems
that another GTP-dependent conformationally active region of
full-length Irgm1 must contribute to the phagosomal accumulation
of the protein.
An alanine scan was performed to investigate the nature of the
interaction of the EGFP-Irgm1 aK construct with Golgi or
lysosomal membranes (Figure 5). Single mutations for each
individual residue in the aK helical region and double/quadruple
mutations for hydrophobic residues did not change the Golgi/
lysosomal localisation of EGFP-Irgm1 aK. The localisation was
also unaffected by single changes to charged or polar residues in
the helical region. However, when two or more non-hydrophobic
residues were substituted by alanines, EGFP-Irgm1 aK was
distributed generally throughout the cytoplasm, overlapping
neither with GM130 nor with LAMP1, and was possibly in the
soluble compartment. These results suggest that both the overall
amphipathicity of the aK helix and the identity of the non-
hydrophobic residues contribute together to the membrane and
Golgi/lysosome localisation of the aK helix. The insensitivity of
the targeting specificity to exchanges of the hydrophobic residues
to alanine suggests that the main function of these residues is to
present a hydrophobic face and associate with the lipid component
of the membrane [20]. The contribution of the non-hydrophobic
residues needs further analysis as it is unclear whether the effect
observed from the double/triple non-hydrophobic-residue to
alanine mutations is primarily due to an increase in overall
hydrophobicity or to the loss of the specific polar side-chains. In
addition, there are two basic residues (K349, R351) and three
large hydrophobic residues (L350, L352, M353) preceding the
predicted amphipathic helix that were not analyzed in the present
study. Altogether there is a high frequency of basic residues in the
aK targeting sequence, the positive charges associated with the
sequence may be necessary to increase the overall affinity of the
sequence for the negatively charged head groups on the cytosolic
face of the membrane. It is certainly not excluded that the aK
targeting sequence may be targeted to bind to specific phospho-
inositides as suggested recently [19,23].
Not only Irgm1, but all mouse IRGM proteins have a
membrane-targeting signal in the position of the aK helix in the
Irga6 crystal structure. The aK helix from Irgm2 targets EGFP to
the Golgi apparatus and the aK helix from Irgm3 targets EGFP to
a reticular endomembrane system, both localisations that largely
correspond to those of the respective full-length proteins [1].
Efforts to purify untagged IRGM proteins for biochemical analysis
have not been successful so far. We therefore took advantage of
synthetic small targeting peptides to study the subcellular
localisation of IRGM proteins. The aK peptide from Irgm1 was
a pioneer for this approach. There are several advantages to the
peptide-streptavidin tetramer system described here. First, the
targeting aK helix peptide from Irgm1 was insoluble in neutral pH
buffers, but when loaded onto streptavidin protein, the solubility of
the complex at neutral pH was adequate for experiment.
Secondly, streptavidin is a natural tetrameric protein and each
molecule has the capacity to bind four biotinylated peptides,
resulting in enhanced avidity of the targeting complex to its target.
Thirdly, streptavidin can be covalently labelled with fluoro-
chromes and used directly in fluoro-cytochemistry staining. Irgm1
aK peptide has been shown in the present study to successfully
mimic the localisation of endogenous full-length Irgm1 in both
Golgi apparatus and lysosomal compartments in MEFs (Figure 6)
and L929 cells (not shown).
While the present paper was under review a report appeared
concluding that the aK targeting sequence of Irgm1 is specific for
the two phosphoinositides PI(3,4)2P and PI(3,4,5)3P formed at the
mycobacterial phagosome during pathogen uptake [19]. The
methods and conclusions of that paper touch those of the present
paper at several points and deserve comment. Firstly, that study
makes extensive use of Irgm1 constructs tagged either at the N- or
C-terminus with EGFP or its derivatives, but mislocalisation of
such constructs was not observed. While Golgi localisation of the
endogenous protein and of an EGFP-Irgm1 aK construct
apparently identical to our own [20] was reported, no localisation
of either to a LAMP1 compartment was reported in uninfected
cells. Finally, localisation of the EGFP-Irgm1 aK construct to the
mycobacterial phagosome was reported while we found no
localisation of the EGFP-Irgm1 aK construct to latex bead
phagosomes. One possible reconciliation of these two disparate
sets of findings is the different cell types used. Tiwari and
colleagues [19] employed a variety of cell types, including primary
bone-marrow-derived macrophages and RAW264.7 macrophag-
es, while our studies were largely on mouse primary embryonic
fibroblasts. Our use of MEFs was dictated by the far superior
properties of these cells for organelle identification and signal co-
localisation. We have, however, in our own experiments seen no
discrepancies so far between RAW264.7 cells and the localisations
that we illustrate here with MEFs. In particular, endogenous
IFNc-induced Irgm1 clearly localised to the Golgi in RAW264.7
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Irgm1 constructs did not localise detectably to the Golgi in these
cells (Supplementary Figure S1).
In summary, this report documents two critical properties of
Irgm1 in mouse fibroblasts, both of which should be taken
seriously when working on this interesting resistance protein.
Firstly, native, IFNc-induced Irgm1 localises to endolysosomal
membranes as well as to Golgi, and secondly, both N- and C-
terminally EGFP-tagged Irgm1 localise abnormally and should
probably not be used for functional studies on the role of Irgm1 in
cells.
Materials and Methods
Expression Constructs
EGFP-Irgm1 aK, EGFP-Irgm1, Irgm1-EGFP (pF25), pGW1H-
Irgm1, pGW1H-Irgm1 S90N, pGW1H-Irgm1 ins 362, 367E
constructs were generated as described [14,20]. Site directed
mutagenesis was performed by the Quik-Change Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA).
Cells and Tissue Culture
Experiments involving the preparation of mouse embryonic
fibroblasts (MEFs) from 14 day pregnant females were performed
following the guidelines given in Anzeige Nr. 9.93.2.10.44.07.189
to licence Nr: 50.203.2-K 13, 21/02 ‘‘Cell-biological basis of
innate immunity’’ issued by LANUV NRW (North Rhine-
Westphalia).
C57BL/6 embryonic fibroblasts (MEFs) were prepared from
mice at day 14 post coitum and cultured in DMEM (high glucose)
(Invitrogen, Carlsbad, CA) supplemented with 10% FCS (Bio-
chrom AG, Berlin, Germany), 2 mM L-glutamine, 1 mM sodium
pyruvate, non-essential amino acids, 100 U/ml penicillin,
100 mg/ml streptomycin (all PAA, Pasching, Austria). Cells were
transiently transfected using FuGENE6 (Roche, Basel, Switzer-
land) according to the manufacturer’s instructions. Mouse IFNc
was purchased from PeproTech, NJ, USA.
Transferrin Uptake Experiments
Cells were grown on coverslips and starved for 1 hour in FCS-
free medium. To label early endosomes, Alexa-546 labeled human
Transferrin (Molecular Probes, Carlsbad, CA) was diluted to a
final concentration of 5 mg/ml into the FCS-free medium, and
cells were incubated at 37uC, 7.5% CO2 for 5 minutes. Cells were
then fixed with ice-cold 3% PFA in PBS for 20 minutes. To label
recycling endosomes, the cells were incubated with FCS-free
medium with diluted transferrin for 10 minutes after starvation,
then washed 3 times with ice-cold PBS. Complete medium was
added afterwards and the cells were incubated at 37uC, 7.5% CO2
for 30 minutes. Finally cells were fixed with ice-cold 3% PFA in
PBS for 20 minutes followed by three washes with PBS and stained
for immunofluorescence.
Lysotracker Loading Experiments
Lysotracker Red DND-99 (Molecular Probes) was diluted to a
final concentration of 50 nM in complete medium and the cells
were incubated at 37uC, 7.5% CO2 for 20 minutes. Cells were
then fixed with ice-cold 3% PFA in PBS for 20 minutes followed
by three washes with PBS and stained for immunofluorescence.
Latex Bead Phagocytosis Experiments
MEFs were grown on the coverslips, treated with 200 U/ml
IFNc and/or transfected with indicated constructs for 24 hours.
During the IFNc-treatment and/or transfection procedure, 2 mm
carboxylated latex beads (Polysciences, Warrington, PA) were
added to the culture at a dilution of 1:1000, and the cells were
incubated with the latex beads at 37uC overnight. The latex beads
were extensively phagocytosed by the MEFs through unidentified
receptors. Finally the cells were fixed with 3% PFA for 20 minutes
at room temperature and stained for immunofluorescence.
Peptide-Streptavidin Complexes
The Irgm1 aK peptide H-SK(Biotin)LRLMTCAIV-
NAFFRLLRFLPCVCC-OH was synthesized by JPT Peptide
Technologies GmbH, Berlin.
The peptide was biotinylated on Lysine at the second position of
the sequence. The peptide was dissolved in 10 mM NaAc pH 4.5
buffer with 10 mM TCEP as reducing agent and stored at 280uC
at a stock concentration of ,100 mM. The absolute absorbance of
the Irgm1 aK peptide at 230 nm in the dissolving buffer was
,0.46/100 mM.
The peptide-Cy3-streptavidin complex was made in the
blocking buffer used for the immunofluorescence staining (PBS
pH 7.4/0.1% saponin/1% BSA with additional 2 mM DTT).
The Cy3-labelled streptavidin (Sigma, S6402) was first diluted in
the blocking buffer to a final concentration of 20 mg/ml (0.33 mM).
The peptide stock solution was then added to the streptavidin
solution with a titration from 4:1 to 50:1 molar ratio (peptide to
streptavidin). The optimum ratio was experimentally determined
based on the staining signals (8 mM peptide in the Figure 6). The
peptide-streptavidin solution was mixed and precipitated material
removed by centrifugation at 45.000 rpm for 30 minutes. The
supernatant was recovered and antibodies against the indicated
proteins added. This solution was used like a primary antibody in
immunofluorescence staining, and was incubated with PFA-fixed
saponin permeabilized cells at 37uC for 1 hour. The peptide-
streptavidin images were obtained in the Cy3 channel.
Immunofluorescent Staining
Immunofluorescent staining was performed on paraformalde-
hyde-fixed cells essentially as described earlier [20]. Images were
taken with a Zeiss Axioplan II fluorescence microscope equipped
with an AxioCam MRm camera (Zeiss) and processed with
Axiovision 4.6 software (Zeiss). 49,6-Diamidine-29-phenylindole
dihydrochloride (DAPI, Invitrogen) was used for nuclear counter-
staining at a final concentration of 0.5 mg/ml.
Immunoreagents
The following serological reagents were used for immunofluo-
rescence at the indicated concentrations: anti-Irgm1 goat poly-
clonal antibody P20 (1:100, Santa Cruz Biotechnology), anti-
Irgm1 mouse monoclonal antibody 1B2 (supernatant recovered
from hybridoma cell culture [24]), anti-Irgm2 rabbit antiserum
H53 (1:1000, [6]), anti-GM130 mouse monoclonal antibody
(1:1000, BD Transduction Lab, 610822), anti-TGN38 goat
polyclonal antibody S-20 (1:100, Santa Cruz Biotechnology),
anti-CI-M6PR rabbit antiserum (1:100, a gift from Albert Haas,
University of Bonn), anti-LAMP1 rat monoclonal antibody 1D4B
(1:1000, University of Iowa, USA), goat anti-mouse Alexa 488 and
546, goat anti-rabbit Alexa 488 and 546, donkey anti-rat Alexa
488, donkey anti-goat Alexa 350, 488, 546 and 647, donkey anti-
mouse Alexa 488, 555 and 647, donkey anti-rabbit Alexa 488, 555
and 647 (1:1000, Molecular Probes, Invitrogen).
The specificity of the two anti-Irgm1 reagents used, monoclonal
1B2 and goat serum P20 was confirmed by staining IFNc-induced
MEFs from Irgm1-deficient mice (Figure S2). No staining was
detected, compared with strong typical Irgm1 localisation patterns
in wild type MEFs stained with the same reagents at the same time.
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Figure S1 Mislocalisation of Irgm1-EGFP (pF25) tagged con-
struct in RAW264.7 macrophages. RAW 264.7 macrophages were
transfected with the pF25 Irgm1-EGFP C-terminal tagged
construct as described in Materials and Methods, and induced
for 24 h with 100 U IFNc (panels A) or not induced (panels B). A
further set of RAW264.7 macrophages were induced with 100 U
IFNc but not transfected (panels C). After 24 hr, all cells were
fixed and stained for the Golgi membrane marker, GM130.
Untransfected cells (panels C) were also stained with goat anti
Irgm1 serum P20. EGFP and Alexa-488 donkey anti-goat were
detected at 488 nm (green), while GM130 was detected with
Alexa-555 donkey anti mouse at 555 nm (red). Nuclei were
counterstained with DAPI The transfected pF25 construct labelled
multiple unidentified cytoplasmic components, but failed to
localise to the Golgi as defined by GM130. In contrast, anti-
Irgm1 serum P20 clearly co-localised with GM130, with additional
weak staining of other cytoplasmic components. In further
stainings, transfected pF25 could be partially localised to a
LAMP1-positive compartment (not shown).
Found at: doi:10.1371/journal.pone.0008648.s001 (4.38 MB TIF)
Figure S2 Specificity controls for goat anti Irgm1 antiserum P20
and mouse anti Irgm1 monoclonal 1B2. The two anti-Irgm1
reagents were used to stain primary MEFs induced for 24 hr with
100 U IFNg, followed by appropriate fluoresceinated secondary
anti-immunoglobulin reagents (see Materials and Methods). MEFs
were from wild-type C57BL/6 (top row) or from Irgm1-deficient
C57BL/6 mice (Collazo et al). See Materials and Methods for
further details. For both primary Irgm1-specific reagents typical
Golgi and cytoplasmic staining was observed in the wild-type
MEFs, while only barely visible cytoplasmic staining was seen in
the Irgm1-deficient MEFs.
Found at: doi:10.1371/journal.pone.0008648.s002 (4.48 MB TIF)
Table S1 C57BL/6 MEFs were induced for 24 h with IFNc at
100 U/ml. They were then stained according to Materials and
Methods with one or the other of two triple staining protocols,
above. The co-localisation of Irgm1 with the standard lysosomal
(LAMP-1) marker, or anti- Irgm2 as a Golgi marker (Martens and
Howard, 2006 The Interferon-Inducible GTPases. Annu Rev Cell
Dev Biol 22: 559–589) was recorded in approximately 50 cells for
each protocol. It is clear that weak and strong Golgi staining is
randomly associated with weak or strong lysosomal staining.
Found at: doi:10.1371/journal.pone.0008648.s003 (0.04 MB
DOC)
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